Annual Accounts Payable
$6.04 M
-$21.22 M-77.83%
31 December 2023
Summary:
PTC Therapeutics annual accounts payable is currently $6.04 million, with the most recent change of -$21.22 million (-77.83%) on 31 December 2023. During the last 3 years, it has fallen by -$12.62 million (-67.61%). PTCT annual accounts payable is now -77.83% below its all-time high of $27.27 million, reached on 31 December 2022.PTCT Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$13.29 M
-$10.99 M-45.25%
30 September 2024
Summary:
PTC Therapeutics quarterly accounts payable is currently $13.29 million, with the most recent change of -$10.99 million (-45.25%) on 30 September 2024. Over the past year, it has dropped by -$5.86 million (-30.60%). PTCT quarterly accounts payable is now -51.59% below its all-time high of $27.46 million, reached on 31 March 2024.PTCT Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PTCT Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -77.8% | -30.6% |
| 3 y3 years | -67.6% | -38.1% |
| 5 y5 years | +0.7% | +48.4% |
PTCT Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -77.8% | at low | -51.6% | +119.9% |
| 5 y | 5 years | -77.8% | +0.7% | -51.6% | +119.9% |
| alltime | all time | -77.8% | +872.5% | -51.6% | +4835.8% |
PTC Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $13.29 M(-45.3%) |
| June 2024 | - | $24.28 M(-11.6%) |
| Mar 2024 | - | $27.46 M(+354.2%) |
| Dec 2023 | $6.04 M(-77.8%) | $6.04 M(-68.4%) |
| Sept 2023 | - | $19.15 M(-25.6%) |
| June 2023 | - | $25.74 M(-2.2%) |
| Mar 2023 | - | $26.31 M(-3.5%) |
| Dec 2022 | $27.27 M(+18.4%) | $27.27 M(+30.7%) |
| Sept 2022 | - | $20.86 M(-8.8%) |
| June 2022 | - | $22.88 M(+24.6%) |
| Mar 2022 | - | $18.36 M(-20.3%) |
| Dec 2021 | $23.03 M(+23.4%) | $23.03 M(+7.3%) |
| Sept 2021 | - | $21.46 M(+3.1%) |
| June 2021 | - | $20.82 M(+8.9%) |
| Mar 2021 | - | $19.11 M(+2.4%) |
| Dec 2020 | $18.66 M(+80.8%) | $18.66 M(+19.2%) |
| Sept 2020 | - | $15.66 M(+1.3%) |
| June 2020 | - | $15.46 M(-3.8%) |
| Mar 2020 | - | $16.07 M(+55.7%) |
| Dec 2019 | $10.32 M(+72.0%) | $10.32 M(+15.2%) |
| Sept 2019 | - | $8.96 M(-12.3%) |
| June 2019 | - | $10.22 M(+4.4%) |
| Mar 2019 | - | $9.79 M(+63.1%) |
| Dec 2018 | $6.00 M | $6.00 M(-8.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2018 | - | $6.54 M(+49.8%) |
| June 2018 | - | $4.36 M(+40.6%) |
| Mar 2018 | - | $3.10 M(-79.7%) |
| Dec 2017 | $15.28 M(+142.6%) | $15.28 M(+155.0%) |
| Sept 2017 | - | $5.99 M(-1.1%) |
| June 2017 | - | $6.06 M(+69.4%) |
| Mar 2017 | - | $3.58 M(-43.2%) |
| Dec 2016 | $6.30 M(+9.0%) | $6.30 M(-67.3%) |
| Sept 2016 | - | $19.24 M(+14.5%) |
| June 2016 | - | $16.80 M(+4.8%) |
| Mar 2016 | - | $16.02 M(+177.3%) |
| Dec 2015 | $5.78 M(+40.0%) | $5.78 M(-33.7%) |
| Sept 2015 | - | $8.71 M(+155.9%) |
| June 2015 | - | $3.41 M(+8.5%) |
| Mar 2015 | - | $3.14 M(-24.0%) |
| Dec 2014 | $4.13 M(+267.3%) | $4.13 M(+696.9%) |
| Sept 2014 | - | $518.00 K(-15.5%) |
| June 2014 | - | $613.00 K(+58.4%) |
| Mar 2014 | - | $387.00 K(-65.6%) |
| Dec 2013 | $1.12 M(+80.8%) | $1.12 M(+10.5%) |
| Sept 2013 | - | $1.02 M(+139.1%) |
| June 2013 | - | $425.40 K(+58.0%) |
| Mar 2013 | - | $269.30 K(-56.7%) |
| Dec 2012 | $621.60 K(-66.9%) | $621.60 K |
| Dec 2011 | $1.88 M | - |
FAQ
- What is PTC Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for PTC Therapeutics?
- What is PTC Therapeutics annual accounts payable year-on-year change?
- What is PTC Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for PTC Therapeutics?
- What is PTC Therapeutics quarterly accounts payable year-on-year change?
What is PTC Therapeutics annual accounts payable?
The current annual accounts payable of PTCT is $6.04 M
What is the all time high annual accounts payable for PTC Therapeutics?
PTC Therapeutics all-time high annual accounts payable is $27.27 M
What is PTC Therapeutics annual accounts payable year-on-year change?
Over the past year, PTCT annual accounts payable has changed by -$21.22 M (-77.83%)
What is PTC Therapeutics quarterly accounts payable?
The current quarterly accounts payable of PTCT is $13.29 M
What is the all time high quarterly accounts payable for PTC Therapeutics?
PTC Therapeutics all-time high quarterly accounts payable is $27.46 M
What is PTC Therapeutics quarterly accounts payable year-on-year change?
Over the past year, PTCT quarterly accounts payable has changed by -$5.86 M (-30.60%)